Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Chelsea Therapeutics International Ltd.

Headquarters: Charlotte, NC, United States of America
Website: N/A
Year Founded: 2002
Status: Acquired

BioCentury | Oct 18, 2022
Product Development

Lundbeck pivot emphasizes first in class in revamped pipeline

Dunsire era brings new blood to R&D, appetite for risk, and open doors for partnering
BioCentury | Mar 8, 2017
Company News

Management tracks

BioCentury | Mar 2, 2017
Company News

Management tracks

BioCentury | Sep 8, 2014
Company News

Lundbeck sales and marketing update

BioCentury | Jun 30, 2014
Company News

Lundbeck, Chelsea Therapeutics deal

BioCentury | Jun 2, 2014
Company News

Chelsea Therapeutics, Lundbeck deal

BioCentury | May 12, 2014
Company News

Chelsea Therapeutics, Lundbeck deal

BioCentury | May 12, 2014
Finance

Highlights of weekly biotech stock moves

Regulatory, clinical and other milestones
BioCentury | May 9, 2014
Top Story

Lundbeck to acquire Chelsea

BioCentury | Mar 17, 2014
Finance

Highlights of weekly biotech stock moves

Regulatory, clinical and other milestones
Items per page:
1 - 10 of 215